Medline Inc. (MDLN)
Nasdaq · Northfield, Illinois, USA · Founded 1966 · CEO Jim Boyle
Valuation summary
$38.56 fair value versus $37.84 in the market, a difference of +1.9%. Rated Hold.
| Fair value per share | $38.56 |
| Current share price | $37.84 |
| Upside / downside | +1.9% |
| Bear case | $18.82 |
| Bull case | $68.62 |
| Discount rate (WACC) | 8.9% |
| Terminal growth | 2.50% |
| Market capitalisation | $50B |
| EV / Sales | 2.0x |
About Medline Inc.
Founded in 1966 by brothers Jim and Jon Mills, whose family had made nurses' uniforms and surgical gowns since 1910. Blackstone, Carlyle and Hellman & Friedman bought a majority stake in 2021, and the company listed on Nasdaq in December 2025 in the largest US flotation of that year. Jim Boyle is chief executive. Medline makes and distributes medical supplies — gloves, gowns, surgical kits, wound care — to hospitals, nursing homes and doctors' offices, and is the largest company of its kind in the United States.
Investment case
- Makes many of its own products, which earn more than distributing other people's.
- Long contracts with large hospital systems and a record of winning them from rivals.
- Decades of uninterrupted sales growth.
Key risks
- Carries significant debt from the 2021 buyout.
- Tariffs on products made in Asia and Mexico raise costs.
- Private-equity owners still hold large stakes they will sell over time.
Revenue by segment
| Medline Brand products | 48% |
| Supply chain solutions | 52% |
Five-year forecast
| Revenue | Free cash flow | |
|---|---|---|
| Year 1 | $33.8B | $2.2B |
| Year 2 | $37.3B | $2.5B |
| Year 3 | $41.0B | $3.0B |
| Year 4 | $44.9B | $3.5B |
| Year 5 | $49.1B | $4.0B |
What the street says
Welcomed as a steady, high-quality new listing; debt and shareholder sales are the watch points.
Comparable companies: BSX · GEHC · CAH · IQV · CI · HUM · DXCM · ELV
Open the interactive model, price chart and sensitivity grid →